A citation-based method for searching scientific literature

Nasrien E Ibrahim, Cian P McCarthy, Shreya Shrestha, Hanna K Gaggin, Renata Mukai, Jackie Szymonifka, Fred S Apple, John C Burnett, Seethalakshmi Iyer, James L Januzzi. J Am Coll Cardiol 2019
Times Cited: 61







List of co-cited articles
421 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
57

B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial.
Peder Langeland Myhre, Muthiah Vaduganathan, Brian Claggett, Milton Packer, Akshay S Desai, Jean L Rouleau, Michael R Zile, Karl Swedberg, Martin Lefkowitz, Victor Shi,[...]. J Am Coll Cardiol 2019
76
39

Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study.
Hélène Nougué, Théo Pezel, François Picard, Malha Sadoune, Mattia Arrigo, Florence Beauvais, Jean-Marie Launay, Alain Cohen-Solal, Nicolas Vodovar, Damien Logeart. Eur J Heart Fail 2019
73
31

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
29

Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure.
Milton Packer, John J V McMurray, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. Circulation 2015
418
27

Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.
Eric J Velazquez, David A Morrow, Adam D DeVore, Carol I Duffy, Andrew P Ambrosy, Kevin McCague, Ricardo Rocha, Eugene Braunwald. N Engl J Med 2019
420
24

Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction.
James L Januzzi, Margaret F Prescott, Javed Butler, G Michael Felker, Alan S Maisel, Kevin McCague, Alexander Camacho, Ileana L Piña, Ricardo A Rocha, Amil M Shah,[...]. JAMA 2019
186
22

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Scott D Solomon, John J V McMurray, Inder S Anand, Junbo Ge, Carolyn S P Lam, Aldo P Maggioni, Felipe Martinez, Milton Packer, Marc A Pfeffer, Burkert Pieske,[...]. N Engl J Med 2019
680
22

Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure.
Kevin Damman, Mauro Gori, Brian Claggett, Pardeep S Jhund, Michele Senni, Martin P Lefkowitz, Margaret F Prescott, Victor C Shi, Jean L Rouleau, Karl Swedberg,[...]. JACC Heart Fail 2018
138
18

Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
Akshay S Desai, Scott D Solomon, Amil M Shah, Brian L Claggett, James C Fang, Joseph Izzo, Kevin McCague, Cheryl A Abbas, Ricardo Rocha, Gary F Mitchell. JAMA 2019
104
16

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
Scott D Solomon, Michael Zile, Burkert Pieske, Adriaan Voors, Amil Shah, Elisabeth Kraigher-Krainer, Victor Shi, Toni Bransford, Madoka Takeuchi, Jianjian Gong,[...]. Lancet 2012
717
16

Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial.
Jelena P Seferovic, Brian Claggett, Sara B Seidelmann, Ellen W Seely, Milton Packer, Michael R Zile, Jean L Rouleau, Karl Swedberg, Martin Lefkowitz, Victor C Shi,[...]. Lancet Diabetes Endocrinol 2017
147
14

Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi).
Jessie Gu, Adele Noe, Priya Chandra, Suliman Al-Fayoumi, Monica Ligueros-Saylan, Ramesh Sarangapani, Suzanne Maahs, Gary Ksander, Dean F Rigel, Arco Y Jeng,[...]. J Clin Pharmacol 2010
327
13

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
Alan S Maisel, Padma Krishnaswamy, Richard M Nowak, James McCord, Judd E Hollander, Philippe Duc, Torbjørn Omland, Alan B Storrow, William T Abraham, Alan H B Wu,[...]. N Engl J Med 2002
13


2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways.
Clyde W Yancy, James L Januzzi, Larry A Allen, Javed Butler, Leslie L Davis, Gregg C Fonarow, Nasrien E Ibrahim, Mariell Jessup, JoAnn Lindenfeld, Thomas M Maddox,[...]. J Am Coll Cardiol 2018
156
11


NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.
James L Januzzi, Roland van Kimmenade, John Lainchbury, Antoni Bayes-Genis, Jordi Ordonez-Llanos, Miguel Santalo-Bel, Yigal M Pinto, Mark Richards. Eur Heart J 2006
699
11


Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
Michael R Zile, Brian L Claggett, Margaret F Prescott, John J V McMurray, Milton Packer, Jean L Rouleau, Karl Swedberg, Akshay S Desai, Jianjian Gong, Victor C Shi,[...]. J Am Coll Cardiol 2016
169
11

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Monica M Colvin, Mark H Drazner, Gerasimos S Filippatos, Gregg C Fonarow, Michael M Givertz,[...]. Circulation 2017
11

Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation.
Duk-Hyun Kang, Sung-Ji Park, Sung-Hee Shin, Geu-Ru Hong, Sahmin Lee, Min-Seok Kim, Sung-Cheol Yun, Jong-Min Song, Seung-Woo Park, Jae-Joong Kim. Circulation 2019
136
11

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).
Milton Packer, Robert M Califf, Marvin A Konstam, Henry Krum, John J McMurray, Jean-Lucien Rouleau, Karl Swedberg. Circulation 2002
467
11

A Test in Context: Neprilysin: Function, Inhibition, and Biomarker.
Antoni Bayes-Genis, Jaume Barallat, A Mark Richards. J Am Coll Cardiol 2016
127
9

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Monica M Colvin, Mark H Drazner, Gerasimos S Filippatos, Gregg C Fonarow, Michael M Givertz,[...]. J Am Coll Cardiol 2017
9

Natriuretic peptides in cardiovascular diseases: current use and perspectives.
Massimo Volpe, Speranza Rubattu, John Burnett. Eur Heart J 2014
164
9


2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur J Heart Fail 2016
9

Renal effects of Sacubitril/Valsartan in heart failure with reduced ejection fraction: a real life 1-year follow-up study.
Francesco Spannella, Marco Marini, Federico Giulietti, Giulia Rosettani, Matteo Francioni, Gian Piero Perna, Riccardo Sarzani. Intern Emerg Med 2019
25
24

Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations.
Christian Mueller, Kenneth McDonald, Rudolf A de Boer, Alan Maisel, John G F Cleland, Nikola Kozhuharov, Andrew J S Coats, Marco Metra, Alexandre Mebazaa, Frank Ruschitzka,[...]. Eur J Heart Fail 2019
174
9

Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
Orly Vardeny, Brian Claggett, Jessica Kachadourian, Akshay S Desai, Milton Packer, Jean Rouleau, Michael R Zile, Karl Swedberg, Martin Lefkowitz, Victor Shi,[...]. Eur J Heart Fail 2019
65
9

Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease.
Richard Haynes, Parminder K Judge, Natalie Staplin, William G Herrington, Benjamin C Storey, Angelyn Bethel, Louise Bowman, Nigel Brunskill, Paul Cockwell, Michael Hill,[...]. Circulation 2018
77
9

Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction.
Adriaan A Voors, Mauro Gori, Licette C Y Liu, Brian Claggett, Michael R Zile, Burkert Pieske, John J V McMurray, Milton Packer, Victor Shi, Martin P Lefkowitz,[...]. Eur J Heart Fail 2015
121
9

Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF).
James L Januzzi, Javed Butler, Emmanuel Fombu, Alan Maisel, Kevin McCague, Ileana L Piña, Margaret F Prescott, Jerome B Riebman, Scott Solomon. Am Heart J 2018
42
11

Effect of nesiritide in patients with acute decompensated heart failure.
C M O'Connor, R C Starling, A F Hernandez, P W Armstrong, K Dickstein, V Hasselblad, G M Heizer, M Komajda, B M Massie, J J V McMurray,[...]. N Engl J Med 2011
842
8

Improved Insulin Sensitivity With Angiotensin Receptor Neprilysin Inhibition in Individuals With Obesity and Hypertension.
J Jordan, R Stinkens, T Jax, S Engeli, E E Blaak, M May, B Havekes, C Schindler, D Albrecht, P Pal,[...]. Clin Pharmacol Ther 2017
60
8

Impact of obesity on plasma natriuretic peptide levels.
Thomas J Wang, Martin G Larson, Daniel Levy, Emelia J Benjamin, Eric P Leip, Peter W F Wilson, Ramachandran S Vasan. Circulation 2004
697
8

N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study.
James L Januzzi, Annabel A Chen-Tournoux, Robert H Christenson, Gheorghe Doros, Judd E Hollander, Phillip D Levy, John T Nagurney, Richard M Nowak, Peter S Pang, Darshita Patel,[...]. J Am Coll Cardiol 2018
61
8

Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
G Michael Felker, Kevin J Anstrom, Kirkwood F Adams, Justin A Ezekowitz, Mona Fiuzat, Nancy Houston-Miller, James L Januzzi, Daniel B Mark, Ileana L Piña, Gayle Passmore,[...]. JAMA 2017
243
8

Structural substrate conditions required for neutral endopeptidase-mediated natriuretic Peptide degradation.
Kristin Pankow, Anja Schwiebs, Matthias Becker, Wolf-Eberhard Siems, Gerd Krause, Thomas Walther. J Mol Biol 2009
37
13

Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Alan Maisel, Christian Mueller, Richard Nowak, W Frank Peacock, Judd W Landsberg, Piotr Ponikowski, Martin Mockel, Christopher Hogan, Alan H B Wu, Mark Richards,[...]. J Am Coll Cardiol 2010
364
8

Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.
Chaitanya Madamanchi, Hassan Alhosaini, Arihiro Sumida, Marschall S Runge. Int J Cardiol 2014
125
8

Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides.
Emilia D'Elia, Attilio Iacovoni, Muthiah Vaduganathan, Ferdinando L Lorini, Stefano Perlini, Michele Senni. Eur J Heart Fail 2017
72
8

Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep.
C J Charles, E A Espiner, M G Nicholls, A M Richards, T G Yandle, A Protter, T Kosoglou. Am J Physiol 1996
88
8

Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF.
Craig Balmforth, Joanne Simpson, Li Shen, Pardeep S Jhund, Martin Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor Shi, Scott D Solomon, Karl Swedberg,[...]. JACC Heart Fail 2019
50
10

Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF.
Michael R Zile, Eileen O'Meara, Brian Claggett, Margaret F Prescott, Scott D Solomon, Karl Swedberg, Milton Packer, John J V McMurray, Victor Shi, Martin Lefkowitz,[...]. J Am Coll Cardiol 2019
73
8

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
8

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
Paul W Armstrong, Burkert Pieske, Kevin J Anstrom, Justin Ezekowitz, Adrian F Hernandez, Javed Butler, Carolyn S P Lam, Piotr Ponikowski, Adriaan A Voors, Gang Jia,[...]. N Engl J Med 2020
292
8


Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes.
Marica Bordicchia, Dianxin Liu, Ez-Zoubir Amri, Gerard Ailhaud, Paolo Dessì-Fulgheri, Chaoying Zhang, Nobuyuki Takahashi, Riccardo Sarzani, Sheila Collins. J Clin Invest 2012
594
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.